About AVS Pulse
AVS Pulse is a company based in Ann Arbor (United States) founded in 2017 by Robert Chisena.. AVS Pulse has raised $70.45 million across 5 funding rounds from investors including BioStar Capital and Cue Growth Partners. AVS Pulse offers products and services including Pulse IVL. AVS Pulse operates in a competitive market with competitors including Silk Road Medical, Supira Medical, HDL Therapeutics, Lifetech Scientific Corporation and Shanghai Baixin'an Biotechnology, among others.
- Headquarter Ann Arbor, United States
- Founders Robert Chisena
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Avs Pulse, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$70.45 M (USD)
in 5 rounds
-
Latest Funding Round
$36 M (USD), Series B
Oct 15, 2024
-
Investors
BioStar Capital
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AVS Pulse
AVS Pulse offers a comprehensive portfolio of products and services, including Pulse IVL. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device that fractures arterial calcium using pulsatile waves to restore blood flow.
Unlock access to complete
Unlock access to complete
Funding Insights of AVS Pulse
AVS Pulse has successfully raised a total of $70.45M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $36 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $36.0M
-
First Round
First Round
(07 Jul 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series B - AVS Pulse | Valuation |
investors |
|
| Apr, 2023 | Amount | Series B - AVS Pulse | Valuation | BioStar Capital | |
| Jan, 2023 | Amount | Series B - AVS Pulse | Valuation | BioStar Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AVS Pulse
AVS Pulse has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BioStar Capital and Cue Growth Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AVS Pulse
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AVS Pulse
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avs Pulse Comparisons
Competitors of AVS Pulse
AVS Pulse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, Supira Medical, HDL Therapeutics, Lifetech Scientific Corporation and Shanghai Baixin'an Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of neuroprotection devices for carotid artery disease
|
|
| domain | founded_year | HQ Location |
Developer of ventricular assist devices for coronary intervention and cardiogenic shock
|
|
| domain | founded_year | HQ Location |
Therapy to reverse coronary atherosclerosis is developed using patient plasma.
|
|
| domain | founded_year | HQ Location |
Interventional devices for cardiovascular and vascular diseases are developed.
|
|
| domain | founded_year | HQ Location |
A bioabsorbable coronary rapamycin-eluting stent system is developed using PLLA.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Avs Pulse
Frequently Asked Questions about AVS Pulse
When was AVS Pulse founded?
AVS Pulse was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is AVS Pulse located?
AVS Pulse is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Who is the current CEO of AVS Pulse?
Mark Toland is the current CEO of AVS Pulse.
Is AVS Pulse a funded company?
AVS Pulse is a funded company, having raised a total of $70.45M across 5 funding rounds to date. The company's 1st funding round was a Series B of $20M, raised on Jul 07, 2020.
What does AVS Pulse do?
AVS Pulse was founded in 2017 in Ann Arbor, United States, as a medical device developer focused on cardiovascular interventions. The company creates the PULSE IVL System, a balloon-based platform that delivers pulsatile intravascular lithotripsy therapy. This approach targets severe calcium buildup in leg arteries to restore blood flow. Operations center on device innovation for peripheral artery disease management within the medtech sector.
Who are the top competitors of AVS Pulse?
AVS Pulse's top competitors include Silk Road Medical, Lifetech Scientific Corporation and InterShunt Technologies.
What products or services does AVS Pulse offer?
AVS Pulse offers Pulse IVL.
Who are AVS Pulse's investors?
AVS Pulse has 2 investors. Key investors include BioStar Capital, and Cue Growth Partners.